RIQAS Point of Care EQA

Home - RIQAS

RIQAS Point of Care EQA

RIQAS Point of Care EQA Logo

EQA Designed to Provide Peace of Mind at the Point of Care

Designed to improve the quality of Point of Care Testing (POCT) in locations such as pharmacies, GP surgeries, hospital out patient departments, sports clinics, supermarkets, diagnostic/treatment and walk-in centres.

RIQAS Point of Care EQA provides independent evidence of the accuracy and reliability of test results.

Why RIQAS Point of Care?

Programme Offering

Tests

Role

Matrix

Lipids (Total Cholesterol & HDL Cholesterol)*

  • Risk Factor for heart Disease
  • Monitoring lipid lowering therapy

Whole Blood

HbA1c (Glycated Hemoglobin)*

  • Diagnosing diabetes mellitus
  • Monitoring treatment
  • Encouraging self-management

Whole Blood

CRP (C Reactive Protein)*

  • Early detection of infectious disease
  • Identifying need for antibiotic treatment

Whole Blood

Glucose / Ketones

  • Diagnose and monitor diabetes
  • Monitor the presence of hypoglycemia (low blood glucose) and hyperglycemia (high blood glucose)
  • To determine whether excessive ketones are present in the blood, to detect diabetic ketoacidosis (DKA)

Serum

International Normalised Ratio (INR)

  • Used to measure the effect of anticoagulant drugs such as warfarin
  • Help diagnose a bleeding disorder; to help estimate the severity of liver disease

Whole Blood

  • Key Cycle Dates

    RQ9181
    Distribution Month Sample Distributed Result Submission Deadline
    January 2024 8th January 17th January
    February 2024 5th February 14th February
    March 2024 4th March 13th March
    April 2024 2nd April 10th April
    May 2024 6th  May 15th May
    June 2024 3rd June 12th June
    July 2024 1st  July 10th July
    August 2024 5th August 14th August
    September 2024 2nd September 11th September
    October 2024 7th October 16th October
    November 2024 4th November 13th November
    December 2024 2nd December 11th December
  • What Participants Say

    What participants say

    Our unrivalled commitment to quality and service ensures high levels of customer satisfaction, this is evident from the responses to our latest customer satisfaction survey:

    “All in all a quick and efficient service”

    “Good online system”

    “Very helpful team”

    “Excellent training”

    “They are an experienced team”

    “Very satisfied with the service that we receive”

    “Very good value for money”

    “The website is great”

  • The Importance of Quality Assurance

    Importance of quality assurance

    Quality assurance is an essential aspect of any clinical/diagnostic testing service and is aimed at ensuring the accuracy and reliability of patients’ results. The right result allows the right clinical advice to be offered in a timely manner. Quality assurance operates at two levels:Internal Quality Control

    Internal Quality Control includes operator training/ competency assessment, analyser/ test system maintenance, and adherence to policies/ processes. Whilst some point of care analysers include inbuilt quality checks, cross-check analysis against samples with known levels provides immediate assurance and evidence that a patient’s result is safe to report.External Quality Assessment

    External Quality Assessment involves analysis of samples with unknown levels that have been distributed by an external organisation. Participants are informed how their results compare with other participants, hence providing independent evidence of performance. Increasingly, participation in an external quality assessment scheme is becoming a mandatory requirement where health and healthcare services are being provided.

    EQA provides assurance to both staff and customers that testing provides accurate and reliable results.

Want to know more?

Contact us or download the RIQAS Point of Care catalogue to learn more.

Continue Reading

Frequently Asked Questions

RIQAS

Contact Us


A Comprehensive Guide to External Quality Assessment Programmes

The importance of External Quality Assessment (EQA) programmes in the realm of medical laboratories is beyond dispute. These programmes serve as external control mechanisms, underpinning the accuracy and reliability of diagnostic tests carried out by laboratories across the globe. By participating in EQA programmes, laboratories gain the ability to monitor their proficiency, identify areas for improvement, enhance their analytical performance, and above all, ensure top-tier patient care.

Today, we find ourselves faced with a multitude of EQA programmes, each touting its own, unique features and benefits. Therefore, the question that naturally follows is – how do you choose the right EQA programme for your laboratory?

Understand Your Laboratory’s Requirements

The first step towards selecting an EQA programme is to clearly understand the requirements of your laboratory. These requirements could encompass the range of tests performed, the desired frequency of assessment, and the specific areas where your lab wishes to improve

Examine the EQA Programmes

The next step is to critically examine each EQA programme. Look at the range of tests they cover, the frequency of their assessments, the type of samples they use, and their approach towards feedback and improvement.

Reporting

One of the most critical aspects of an EQA programme is the results reporting mechanism. This mechanism should provide comprehensive and constructive feedback, highlighting areas of improvement, and offering guidance on how to enhance performance. It is also essential to consider the frequency of reporting. More frequent reporting allows laboratories to identify problems and implement corrective actions swiftly, aiding in the continuous improvement of a laboratory and the confident delivery of accurate patient results.

Accreditation

The accreditation of the EQA programme should also be evaluated. Superior programmes are accredited to ISO17043:2010. Participation in an accredited EQA programme is mandatory under ISO15189:2022 accreditation. Choosing a scheme accredited to ISO17043 ensures that the programme has been rigorously evaluated and meets the necessary criteria of a high-quality EQA programme.

Cost-effectiveness

The cost of the EQA programme should be compared to the benefits your laboratory will reap from participating in the scheme. Although cost should not be the sole determining factor, it’s a crucial element to consider. Factors such as consolidation and number of registrations are key areas where many providers differ.

Customer Support

Finally, it’s vital to consider the customer support provided by the EQA programme. Adequate support will ensure that any issues or queries are addressed in a timely and efficient manner

Our latest educational guide Choosing the Right EQA Programme has been constructed to help you with this decision. Providing more detail on the points discussed above and more, this guide displays how the world-renowned RIQAS EQA programmes can help you maximise the accuracy of your laboratory results and achieve ISO15189:2022 accreditation.

In conclusion, selecting the right EQA programme requires a careful and thorough evaluation of several factors. By taking the time to understand your laboratory’s needs, scrutinising each EQA programme, and considering factors such as reporting, accreditation, cost, and customer support, you can make a well-informed decision that will significantly enhance the proficiency of your laboratory and the quality of patient care.

Remember, the primary objective of an EQA programme is to help your laboratory improve. Therefore, the right EQA programme for your laboratory is the one that best assists you in achieving this objective.


What We Do: Cutting-Edge Healthcare Diagnostics

About Randox

You may already be familiar with Randox! Not only do we sponsor the world’s greatest race, the Randox Grand National, we also have a range of sporting partnerships including Team GB, Olimpia Milano basketball team and more. Or perhaps you recognise the name as being one of the partners in the UK Government’s testing programme for COVID-19.

Disruptive Innovation in Diagnostics and Healthcare

Randox is dedicated to improving healthcare using innovative diagnostic technologies, for a range of health conditions including heart disease, diabetes, Alzheimer’s disease, cancer and stroke.

Whilst the science is complex, the applications are not. Diagnostic testing takes place every day behind the scenes of GP surgeries, laboratories and hospitals.

Around 70% of all medical decisions are based on laboratory results, and so, not surprisingly, we believe that earlier, more accurate and more accessible diagnostics are the key to improving global health and saving lives.

The Future of Healthcare

We are significantly increasing our UK High Street presence, using the unique national coronavirus testing infrastructure and capacity we invested in during the pandemic to deliver a new range of preventative health checks. Expansion plans will see up to 20 new Randox Health clinics operating in the UK and Northern Ireland by the end of the year. The clinics will provide easy access for millions to a range of diagnostic tests for vitamin deficiencies, hormone imbalances, inherited/genetic conditions and key health concerns including heart, liver and kidney conditions.

Key to the unique range of diagnostic testing available at our growing network of clinics is the testing technologies, facilities and comprehensive, nationwide distribution network rapidly developed by Randox Laboratories to play a key role in meeting the sudden national demand for Covid-19 PCR tests. At the height of the pandemic emergency, Randox were the only laboratory in the UK and Northern Ireland to process over 100,000 PCR tests per day, saving thousands of lives.

Now, with millions of people having become accustomed to regular testing through the pandemic, Randox is combining that familiarity with its own unique Covid-19 experience and infrastructure to deliver real, affordable and preventative healthcare through early diagnostic testing on the High Street.


“Randox believes that in harnessing the achievements of during the pandemic we can help the shift away from the traditional model of sickness management to a new era of truly preventative healthcare. This will benefit individuals and society by improving patient outcomes and considerably reducing the burden on our vital and hard-pressed clinical services” (Randox founder and Managing Director – Dr Peter FitzGerald).

Frequently Asked Questions?

  • What is the vision of Randox?

    The Randox ethos of improving healthcare, which drove our Managing Director Dr Peter FitzGerald to start the company in the 1980s, continues today. Up to 25% of our turnover is reinvested in research and development to enable our scientists to work on the development of pioneering tests for a range of common illnesses such as cancer, cardiovascular disease and Alzheimer’s disease.

    We have also spent more than £220 million developing our patented Randox Biochip.  This state-of-the-art biochip technology has revolutionised the diagnostics industry because it allows multiple tests to be carried out from a single, undivided patient sample on a single testing platform.

  • When and why was Randox established?

    Our Managing Director Dr FitzGerald established Randox in 1982 in County Antrim, Northern Ireland, to address the need for accurate and readily available diagnostic tests to improve patient diagnosis.  At that time, doctors only conducted a handful of tests per patient, but now, more than 40 years later, Randox has developed and improved hundreds of tests, with hundreds more in development.

  • What products and service do Randox offer?

    Randox has a broad range of products and services that offer a comprehensive insight into patient diagnosis to facilitate more effective disease management and treatment.

    Our clinical product offering includes diagnostic reagents, quality control, and clinical chemistry analysers.

    Our patented Randox Biochip Technology and associated Immunoassay analysers also have applications for forensic toxicology, food diagnostics, and workplace drug testing.

    Our Randox Health clinics offer a range of health checks across general health, sexual health, respiratory health and more. 

  • Who and where are Randox customers?

    Randox’s focus has traditionally been on healthcare providers, so we have placed our products and services in hospitals, clinics, research and molecular laboratories, food testing, forensic toxicology, life sciences and veterinary laboratories.

    With the establishment of our consumer brand, Randox Health, we also offer our innovative tests directly to the consumer in our Randox Health clinics, located across the UK including London, Liverpool, Manchester, Birmingham, Glasgow, Edinburgh, Holywood and Crumlin.

    We have ambitious plans to roll out a number of new clinics across the United Kingdom and internationally, over the coming months and years.

  • What is the size of the company?

    Our company has grown from a small team of two scientists, to over 3300 employees of 44 nationalities, including 650 research scientists and engineers.

     

  • Where are Randox headquartered and what is the geographical reach?

    Our headquarters are in Crumlin, in County Antrim, Northern Ireland – close to Belfast International Airport.  However, we are a global company and currently have offices and distribution outlets in 145 countries, with manufacturing and R&D capabilities in 4 jurisdictions across 3 continents.

    We are currently relocating our headquarters to the Randox Science Park in Antrim; a £161 million project which will accelerate the development of new products into a wide range of clinical needs, including various cancers, stroke, heart disease and neurodegenerative disorders.

    We are very proud of our global penetration – today, approximately 5% of the world’s population receives medical diagnoses using products from Randox.  That equates to about 400 million people. We also supply 15% of the world’s cholesterol tests, so if you’ve ever had your cholesterol checked,  then there’s a high chance it could have been performed using a Randox product!

  • What are the biggest issues within the health sector?

    Our key observation across the globe is that within healthcare the pressure on resources means there is a focus on the “management of sickness,” rather than preventative care. 

    We know that a focus on early diagnosis and preventative care will improve patient outcomes and reduce the burden on healthcare systems.  Making that paradigm shift is a major challenge.  

    That’s why Randox Health was established – to allow the consumer direct access to our innovative technologies so that they can take control of their health and make appropriate lifestyle changes BEFORE disease manifests and symptoms occur.

  • What is Randox doing in the fight against COVID-19?

    To find out more about our test and testing services for COVID-19, visit our COVID-19 FAQ page by clicking here.

Want to know more?

Contact us or visit our dedication to quality webpage.

Our History

Company Values

Our Accreditations


Anti-Müllerian Hormone (AMH) Programme

The RIQAS Anti-Mullerian Hormone (AMH) Programme will be run at a frequency of 1 sample per month. The samples will be in a lyophilised format.

  • Lyophilised material for enhanced stability
  • Submit results and view reports online via RIQAS.Net
  • High quality reliable controls – Randox has 30 plus years’ experience as a global manufacturer of QC controls
  • Worlds largest EQA scheme ensuring peer groups are maximised
  • Monthly reporting to reduce the risk of errors

        What is AMH used for?

        AMH is made in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on age and gender.

        An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy. A woman’s ovaries can make thousands of eggs during her childbearing years. the number declines as a woman gets older. AMH levels help show how many potential egg cells a woman has left. This is known as the ovarian reserve. 

        If a woman’s ovarian reserve is high, she may have a better chance of getting pregnant. She may also be able to wait months or years before trying to get pregnant. If the ovarian reserve is low, it may mean a woman will have trouble getting pregnant and show not delay very long before trying to have a baby.

        AMH tests may also be used to:

        • Predict the start of menopause, a time in a woman’s life when her menstrual periods have stopped, and she can’t
        become pregnant anymore. It usually starts when a woman is around 50 years old.
        • Find out the reason for early menopause
        • Help find out the reason for amenorrhea, the lack of menstruation. It is most often diagnosed in girls who haven’t started
        menstruating by the age of 15 and in women who have missed several periods.
        • Help diagnose polycystic ovary syndrome (PCOS), a hormonal disorder that is a common cause of female infertility, the
        inability to get pregnant
        • Check infants with genitals that are not clearly identified as male or female
        • Monitor women who have certain types of ovarian cancer

        Join the Worlds Largest External Quality Assessment scheme today:

        DescriptionFrequencySizeCat. No
        AMHMonthly (programme begins January 2023)12 x 1mlRQ9198

         


        Microbiology (Bacterial Identification) Programme

        The RIQAS Microbiology Programme includes the identification of micro-organisms to Gram positive/negative, Genus and Species levels, together with Antimicrobial Susceptibility Testing according to chosen Guidelines.

        Available in a bi-monthly format with 3 samples distributed twice per year.  Each strain is presented in a lyophilised pellet form within a self-contained tube containing a pre-filled ampoule for reconstitution, therefore helping to avoid cross contamination.

        • Lyophilised for enhanced stability
        • Multiple registrations allow for comparison between lab staff
        • Possible to be used as a training tool for new and current staff
        • Samples are manufactured to the highest quality
        • Bi-monthly reporting
        • Submit results and view reports online via RIQAS.Net

          Join the Worlds Largest External Quality Assessment scheme today:

          Cat. NoDescriptionFrequencyCycle Start
          RQ9197Microbiology ProgrammeBi-monthly, 3 samples x 2 distributions per yearJuly

           

          Microbiology reports available on RIQAS.net include:

          • Bacterial Identification Report
          • Bacterial Identification – Historical Performance
          • Antimicrobial Susceptibility Testing
          • Cefepime

          WEBINAR | Saudi Arabia MOH (8th December, 2021)

           

           

          Sign up for our webinar – “EQA/PT troubleshooting and corrective action, including for serum indices”

          You are kindly invited to join Randox for a dedicated webinar for the Saudi Ministry of Health on Wednesday 8th December, 2021 at 11:30am (KSA)

          Throughout the webinar, key speaker Stephen Doherty, Global RIQAS manager will provide information on EQA report interpretation and troubleshooting, as well as discussing some of the benefits of EQA assessment of instrument performance on samples affected by serum indices.

           Any questions can be asked before the webinar and we will endeavour to answer them throughout the course of the presentations.

          Sign up for the Webinar Below

          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy (https://www.randox.com/privacy-cookies/)

          WEBINAR | Webinar z zakresu kontroli niezależnych

           

           

           

           

          Webinar z zakresu kontroli niezależnych

          Podczas seminarium internetowego będą Państwo mogli dowiedzieć się więcej na temat kontroli jakości firmy Randox, w tym naszego wiodącego na świecie materiału kontroli wewnętrznej  Acusera oraz zaawansowanego oprogramowania 24.7 do zarządzania danymi kontroli.

          Dodatkowo nie mogą Państwo przegapić szansy wysłuchania eksperta z zakresu kontroli jakości dr Rafała Wlazeł, który opowie o aspektach używania kontroli jakości we współczesnym laboratorium diagnostycznym.

          Tego nie można przegapić. Mogą Państwo uzyskać dostęp do webinaru, korzystając z poniższych linków. Proszę pamiętać, że webinar będzie dostępny w środę 3 listopada 2021.


          WEBINAR | Randox Complete Quality Assurance Solutions

           

           

           

           

          Sign up for our webinar – Randox Complete Quality Assurance Solutions

           

          Delivering a comprehensive yet cost effective EQA solution, RIQAS will help meet regulatory requirements and increase confidence in test system accuracy.

          Throughout this webinar John Parades will focus on the Benefits of RIQAS.

          Join us on Tuesday 26th October, 4pm (PHT) for what is sure to be an informative and educational topic.

          We look forward to welcoming you on the day. Any questions can be asked before the webinar and we will endeavour to answer them throughout the course of the presentations. Additionally, a Q&A will be held at the end where you will get your chance to ask us any questions.

          Sign up for the Webinar Below

          • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy (https://www.randox.com/privacy-cookies/)

          Anti-SARS-CoV-2 External Quality Assessment

          The RIQAS Anti-SARS-CoV-2 EQA programme comprises IgG, IgM and total antibodies. This programme uniquely supports both qualitative and quantitative reporting.

          • Liquid ready-to-use
          • 100% human plasma provides a commutable sample matrix
          • Monthly reporting – 1 sample per month
          • Submit results and view reports online via RIQAS.Net
          • Qualitative and Quantitative reporting options available
          • Rapid report turnaround allows any necessary corrective actions to be made with minimal disruption
          • Allows comparison of different methodologies
          Cat NoKit SizeFrequencyCycle StartParameters
          RQ91932 x (6 x 0.5mL)Monthly (1 sample per month) - 2 distributions per yearOctober3 parameters

          Parameters

          • IgG
          • IgM
          • Total Antibodies

          Please note, product availability may vary country to country.


          Serum Indices External Quality Assessment

          The RIQAS Serum Indices EQA programme is designed for the pre-analytical assessment of Haemolytic, Icteric and Lipemic (HIL) interferences.

          Available in a bi-monthly format with the option to report either quantitative or semi-quantitative results for the HIL parameters, this programme also provides an assessment on how these interferences impact on up to 25 routine chemistry parameters. This provides invaluable information on whether a correct judgement is being made to report results.

          • Lyophilised for enhanced stability
          • Human based serum ensuring commutable sample matrix
          • Bi-monthly reporting
          • HIL parameters include the option of quantitative or semi-quantitative reporting
          • Interpretation of chemistry parameter results
          • Submit results and view reports online via RIQAS.Net

             

            NOTE: If you require additional Serum Indices EQA material, you can purchase RQ9194/A. This is an additional pack containing 9 x 1ml vials to be used as a supplement to your main RQ9194 Serum Indices programme.

            Cat NoKit SizeFrequencyCycle StartReturns
            RQ91942 x (9 x1ml)Bi-monthly (9 samples per distribution), 2 distributions per cycleOctober3 samples bi-monthly

            Indices Assessment (Quantitative and Semi-Quantitative)

            • Haemolysis
            • Icteric
            • Lipemic

            Parameter Assessment (Quantitative)

            • ALP
            • ALT
            • AST
            • D. Bilirubin
            • T. Bilirubin
            • Calcium
            • Chloride
            • Cholesterol
            • CK NAC
            • Creatinine
            • GGT
            • Glucose
            • HDL
            • Iron
            • Lactate
            • LDH
            • Lipase
            • Magnesium
            • Phosphate
            • Potassium
            • Protein Total
            • Sodium
            • Triglycerides
            • Urea
            • Uric Acid

            Request a meeting
            ×
            Make an Enquiry - RX series
            ×
            Make an Enquiry - Reagents
            ×
            Kit Insert Request - Reagents
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Kit Insert Request - Reagents
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - Reagents
            ×
            Make an Enquiry - Quality Control
            ×
            Make an Enquiry - RIQAS
            ×
            Make an Enquiry - RIQAS
            ×
            Make an Enquiry - Quality Control
            ×
            Make an Enquiry
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - Biochip
            • This field is for validation purposes and should be left unchanged.
            ×
            Make an Enquiry - Molecular
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            • This field is for validation purposes and should be left unchanged.
            ×
            Make an Enquiry - Future Diagnostics
            ×
            Make an Enquiry - RX series (Product)
            ×
            Make an Enquiry - Quality Control
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - RIQAS
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Make an Enquiry - Reagents
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            Por favor, introduzca sus datos para ver nuestro último seminario
            ×
            Wyślij zapytanie
            • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje Polityki Prywatności.
            ×
            Wyślij zapytanie
            • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
            ×
            Wyślij zapytanie
            • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
            ×
            Wyślij zapytanie
              Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności .
            ×
            귀하의 문의 사항 제출
              Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            ×
            귀하의 문의 사항 제출
            ×
            귀하의 문의 사항 제출
            ×
            귀하의 문의 사항 제출
            ×
            Downloads
            ×
            Contact

            <p>

              Randox Clinical Chemistry Products Join the Randox Laboratories Mailing List * I would like to receive emails with new product releases and updates from Randox Laboratories, market trends, and more. I do not want to receive email marketing from Randox. Signing up to our mailing list is quick and easy. We do not want to send you any spam or junk emails, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promises never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
            </p>

            ×
            Enquire Now - Coronavirus Testing
            • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details safe and secure. Read more in our Privacy Policy.
            ×